4.7 Article

Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction

Virginia S. Hahn et al.

Summary: In patients with heart failure with preserved ejection fraction (HFpEF), despite high prevalence of obesity and diabetes, myocardial fatty acid metabolism is lower and branched-chain amino acid (BCAA) metabolism is higher compared with heart failure with reduced ejection fraction (HFrEF), suggesting inadequate fuel utilization in HFpEF.

CIRCULATION (2023)

Article Medicine, Research & Experimental

The enhanced mitochondrial dysfunction by cantleyoside confines inflammatory response and promotes apoptosis of human HFLS-RA cell line via AMPK/Sirt 1/NF-ΚB pathway activation

Jinrong Bai et al.

Summary: The study found that Cantleyoside (CA) has anti-inflammatory and pro-apoptotic effects on human rheumatoid arthritis fibroblast synovial cells (HFLS-RA) by activating the AMPK/Sirt 1/NF-kappa B pathway. This suggests that CA may be a potential drug for the treatment of rheumatoid arthritis.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Cardiac & Cardiovascular Systems

MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury

Christian U. Oeing et al.

Summary: The phosphorylation status of TSC2-S1365 plays a crucial role in regulating myocardial substrate utilization, activating mTORC1 to shift metabolism away from fatty acid oxidation towards glycolysis for protection against ischemia-reperfusion injury. Reduced phosphorylation of TSC2-S1365 is also required for effective ischemic preconditioning (IPC) process.

CIRCULATION RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Cardiac Energy Metabolism in Heart Failure

Gary D. Lopaschuk et al.

Summary: Changes in cardiac energy metabolism are complex and depend on the severity and type of heart failure, as well as the presence of common comorbidities such as obesity and type 2 diabetes. The failing heart experiences an energy deficit due to decreased mitochondrial oxidative capacity, compensated for by increased ATP production from glycolysis. Alterations in mitochondrial ATP production fuels and fatty acid oxidation contribute to the inefficiency of the failing heart, with potential therapeutic targets in energy metabolic pathways to improve cardiac function.

CIRCULATION RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Francesco Cosentino et al.

EUROPEAN HEART JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy

Christian U. Oeing et al.

CIRCULATION RESEARCH (2020)

Review Biochemistry & Molecular Biology

PGC-1: The Energetic Regulator in Cardiac Metabolism

Wencheng Di et al.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2018)

Review Peripheral Vascular Disease

Hypertension with diabetes mellitus complications

Daisuke Yamazaki et al.

HYPERTENSION RESEARCH (2018)

Article Geriatrics & Gerontology

Hypertension in patients with type 2 diabetes mellitus: Targets and management

Dimitra Pavlou et al.

MATURITAS (2018)

Review Cardiac & Cardiovascular Systems

2018 ESC/ESH Guidelines for the management of arterial hypertension

Bryan Williams et al.

EUROPEAN HEART JOURNAL (2018)

Review Endocrinology & Metabolism

Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences

Eric Fontaine

FRONTIERS IN ENDOCRINOLOGY (2018)

Review Cardiac & Cardiovascular Systems

Loss of Metabolic Flexibility in the Failing Heart

Qutuba G. Karwi et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)

Review Pharmacology & Pharmacy

Obesity and hypertension

Gino Seravalle et al.

PHARMACOLOGICAL RESEARCH (2017)

Article Biochemistry & Molecular Biology

Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes

Kfir Sharabi et al.

Article Medicine, General & Internal

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

Kristy Iglay et al.

CURRENT MEDICAL RESEARCH AND OPINION (2016)

Article Biochemical Research Methods

The Perseus computational platform for comprehensive analysis of (prote)omics data

Stefka Tyanova et al.

NATURE METHODS (2016)

Article Medicine, Research & Experimental

Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond

Dudley W. Lamming

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)

Article Medicine, Research & Experimental

PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity

Mirko Voelkers et al.

EMBO MOLECULAR MEDICINE (2014)

Article Cardiac & Cardiovascular Systems

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes

Elisa Ramirez et al.

CARDIOVASCULAR DIABETOLOGY (2013)

Article Cardiac & Cardiovascular Systems

Mechanistic Target of Rapamycin Complex 2 Protects the Heart From Ischemic Damage

Mirko Voelkers et al.

CIRCULATION (2013)

Review Cardiac & Cardiovascular Systems

Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes

Stephen C. Kolwicz et al.

CIRCULATION RESEARCH (2013)

Review Cell Biology

Alteration of Energy Substrates and ROS Production in Diabetic Cardiomyopathy

O. Lorenzo et al.

MEDIATORS OF INFLAMMATION (2013)

Article Biochemistry & Molecular Biology

The role of AMPK/mTOR/S6K1 signaling axis in mediating the physiological process of exercise-induced insulin sensitization in skeletal muscle of C57BL/6 mice

Xiaolei Liu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)

Article Cardiac & Cardiovascular Systems

Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways

Ethan J. Anderson et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)

Review Cardiac & Cardiovascular Systems

Insulin Resistance, Obesity, Hypertension, and Renal Sodium Transport

Shoko Horita et al.

INTERNATIONAL JOURNAL OF HYPERTENSION (2011)

Article Cardiac & Cardiovascular Systems

Substrate-Specific Derangements in Mitochondrial Metabolism and Redox Balance in the Atrium of the Type 2 Diabetic Human Heart

Ethan J. Anderson et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Article Biochemical Research Methods

Universal sample preparation method for proteome analysis

Jacek R. Wisniewski et al.

NATURE METHODS (2009)

Article Biochemistry & Molecular Biology

AMPK phosphorylation of raptor mediates a metabolic checkpoint

Dana M. Gwinn et al.

MOLECULAR CELL (2008)

Article Medicine, General & Internal

Trends in prevalence and outcome of heart failure with preserved ejection fraction

Theophilus E. Owan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Review Cardiac & Cardiovascular Systems

Diabetic cardiomyopathy - The search for a unifying hypothesis

IG Poornima et al.

CIRCULATION RESEARCH (2006)

Review Biochemistry & Molecular Biology

Regulation of GLUT4 traffic and function by insulin and contraction in skeletal muscle

F Tremblay et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2003)